tiprankstipranks
Yuyu Pharma, Inc. (KR:000220)
:000220
South Korea Market

Yuyu Pharma, Inc. (000220) Financial Statements

Followers

Yuyu Pharma, Inc. Financial Overview

Yuyu Pharma, Inc.'s market cap is currently ₩55.75B. The company's EPS TTM is ₩; its P/E ratio is 5.16; and it has a dividend yield of 2.98%. Yuyu Pharma, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is ₩―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₩ 140.88B₩ 133.15B₩ 137.21B₩ 138.88B₩ 115.66B
Gross Profit₩ 53.94B₩ 51.70B₩ 48.53B₩ 53.31B₩ 45.34B
Operating Income₩ 11.02B₩ 11.70B₩ 364.54M₩ 691.75M₩ 2.65B
EBITDA₩ 16.63B₩ 18.87B₩ 4.86B₩ 3.40B₩ 6.30B
Net Income₩ 8.15B₩ 8.72B₩ -7.18B₩ -4.43B₩ -920.29M
Balance Sheet
Cash & Short-Term Investments₩ 29.09B₩ 42.65B₩ 32.35B₩ 30.78B₩ 50.26B
Total Assets₩ 207.22B₩ 207.69B₩ 198.21B₩ 195.21B₩ 192.99B
Total Debt₩ 27.92B₩ 33.64B₩ 39.41B₩ 39.28B₩ 39.17B
Net Debt₩ -1.17B₩ -8.19B₩ 8.80B₩ 13.44B₩ -11.10B
Total Liabilities₩ 67.04B₩ 72.62B₩ 77.86B₩ 71.83B₩ 64.30B
Stockholders' Equity₩ 129.28B₩ 125.23B₩ 112.19B₩ 116.82B₩ 124.28B
Cash Flow
Free Cash Flow₩ 7.81B₩ 17.65B₩ -4.69B₩ -11.80B₩ -2.24B
Operating Cash Flow₩ 16.07B₩ 24.95B₩ 420.86M₩ -6.23B₩ 4.51B
Investing Cash Flow₩ -13.15B₩ -4.01B₩ -2.81B₩ -8.54B₩ -5.89B
Financing Cash Flow₩ -15.90B₩ -9.86B₩ 7.16B₩ -9.08B₩ 31.31B
Currency in KRW

Yuyu Pharma, Inc. Earnings and Revenue History

Yuyu Pharma, Inc. Debt to Assets

Yuyu Pharma, Inc. Cash Flow

Yuyu Pharma, Inc. Forecast EPS vs Actual EPS